IS THERE ANY ROLE OF IMMUNOGENICITY ON THE RESPONSE TO THE ANTI-TUMOR NECROSIS FACTOR ALPHA THERAPY IN PATIENTS WITH ANKYLOSING SPONDYLITIS: THE FIRST RESULTS OF A PROSPECTIVE COHORT STUDY

Basit Öğe Kaydı
dc.contributor.authorAkar, S.
dc.contributor.authorCinar, M.
dc.contributor.authorSargin, G.
dc.contributor.authorKaradag, O.
dc.contributor.authorKinikli, G.
dc.contributor.authorOzmen, M.
dc.contributor.authorGercik, O.
dc.contributor.authorKalyoncu, U.
dc.contributor.authorYilmaz, S.
dc.contributor.authorSenturk, T.
dc.contributor.authorKeser, G.
dc.contributor.authorHatemi, G.
dc.contributor.authorYargucu, F.
dc.contributor.authorOzguler, Y.
dc.contributor.authorCefle, A.
dc.contributor.authorKozaci, D.
dc.contributor.authorSolmaz, D.
dc.contributor.authorKisacik, B.
dc.date.accessioned2019-10-27T11:07:31Z
dc.date.available2019-10-27T11:07:31Z
dc.date.issued2017
dc.departmentEge Üniversitesien_US
dc.descriptionAnnual European Congress of Rheumatology -- JUN 14-17, 2017 -- Madrid, SPAINen_US
dc.identifier.doi10.1136/annrheumdis-2017-eular.3729
dc.identifier.endpage354en_US
dc.identifier.issn0003-4967
dc.identifier.issn1468-2060
dc.identifier.startpage354en_US
dc.identifier.urihttps://doi.org/10.1136/annrheumdis-2017-eular.3729
dc.identifier.urihttps://hdl.handle.net/11454/32039
dc.identifier.volume76en_US
dc.identifier.wosWOS:000413181401072en_US
dc.identifier.wosqualityQ1en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isoenen_US
dc.publisherBmj Publishing Groupen_US
dc.relation.ispartofAnnals of the Rheumatic Diseasesen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.titleIS THERE ANY ROLE OF IMMUNOGENICITY ON THE RESPONSE TO THE ANTI-TUMOR NECROSIS FACTOR ALPHA THERAPY IN PATIENTS WITH ANKYLOSING SPONDYLITIS: THE FIRST RESULTS OF A PROSPECTIVE COHORT STUDYen_US
dc.typeConference Objecten_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu